Stocks Health care CWLXF

OTC · Health care

C21 Investments Inc. (CWLXF)

C21 Investments Inc. reported revenue of $32.6M in fiscal 2026, up 8.3% from a year earlier. It posted a net loss of $3.2M. Operating cash flow minus capital spending left $1.1M of free cash flow in fiscal 2026. At March 31, 2026 it held $2.2M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on June 12, 2026.

Watch CWLXF in 60 seconds

What C21 Investments Inc. does

C21 Investments Inc. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on OTC under the ticker CWLXF.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Full financial statements: income, balance sheet and cash flow

Where CWLXF ranks in Health care

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What C21 Investments Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. August 26, 2026
   Deregistration 15-12G
2. August 26, 2026
   Form S-8 POS filing S-8 POS
3. August 26, 2026
   Form S-8 POS filing S-8 POS
4. August 21, 2026
   Foreign issuer update 6-K
5. August 10, 2026
   Foreign issuer update 6-K
6. July 9, 2026
   Foreign issuer update 6-K
7. June 22, 2026
   Foreign issuer update 6-K
8. June 15, 2026
   Foreign issuer update 6-K
9. June 12, 2026
   Annual report (foreign issuer) 20-F · period to March 31, 2026Revenue rose 8.3% to $32.6M versus the prior year; diluted EPS -$0.03 versus -$0.03.
10. June 12, 2026
    Foreign issuer update 6-K

All filings on SEC EDGAR

Questions about CWLXF

What does C21 Investments Inc. do?

C21 Investments Inc. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on OTC under the ticker CWLXF.

Is C21 Investments Inc. profitable?

No. In fiscal 2026 it reported a net loss of $3.2M on revenue of $32.6M.

How much revenue does C21 Investments Inc. make?

In fiscal 2026 C21 Investments Inc. reported revenue of $32.6M. That is 8.3% more than a year earlier.

When did C21 Investments Inc. last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on June 12, 2026. It covers the period to March 31, 2026. Its newest filing of any kind is the deregistration from August 26, 2026.

Similar companies

Compare CWLXF with

Compare CWLXF with any company

Follow CWLXF

Get an email when C21 Investments Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow CWLXF: get an email when it files

Where the numbers come from

Financial figures are the values C21 Investments Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.